Literature DB >> 29065222

Digital quantitative analysis of mast cell infiltration in interstitial cystitis.

Yoshiyuki Akiyama1, Daichi Maeda2, Teppei Morikawa3, Aya Niimi1, Akira Nomiya4, Yukio Yamada5, Yasuhiko Igawa6, Akiteru Goto2, Masashi Fukayama3, Yukio Homma1.   

Abstract

AIMS: To evaluate the significance of mast cell infiltration in interstitial cystitis (IC) by comparison with equally inflamed controls using a digital quantification technique.
METHODS: Bladder biopsy specimens from 31 patients with Hunner type IC and 38 patients with non-Hunner type IC were analyzed. Bladder biopsy specimens from 37 patients without IC, including 19 non-specific chronic cystitis ("non-IC cystitis") specimens and 18 non-inflamed bladder ("normal bladder") specimens, were used as controls. Mast cell tryptase-, CD3-, CD20-, and CD138-immunoreactive cells were quantified using digital image analysis software to evaluate both mast cell and lymphoplasmacytic cell densities. Mast cell and lymphoplasmacytic cell densities were counted independently in the entire lamina propria and detrusor areas and compared among the four groups.
RESULTS: In the lamina propria, there were no significant differences in mast cell and lymphoplasmacytic cell densities between Hunner type IC and non-IC cystitis or between non-Hunner type IC and normal bladder specimens. In the detrusor, the mast cell densities were not significantly different among the four groups. Mast cell density was correlated with lymphoplasmacytic cell density, but not with clinical parameters.
CONCLUSIONS: Mast cell density is not significantly different between IC specimens and non-IC control specimens with a similar degree of background inflammation. The intensity of mast cell infiltration generally correlated with that of lymphoplasmacytic cells. We conclude that mast cell count is of no value in the differential diagnosis between IC and other etiologies.
© 2017 The Authors. Neurourology and Urodynamics Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  cystitis; detrusor; diagnosis; differential; interstitial; mast cells; mastocytosis; urinary bladder

Mesh:

Substances:

Year:  2017        PMID: 29065222     DOI: 10.1002/nau.23365

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  9 in total

1.  Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome.

Authors:  Jeffrey S Schachar; Robert J Evans; Graham E Parks; Joao Zambon; Gopal Badlani; Stephen J Walker
Journal:  Int Urogynecol J       Date:  2019-06-28       Impact factor: 2.894

Review 2.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

3.  Inflammation and Barrier Function Deficits in the Bladder Urothelium of Patients with Chronic Spinal Cord Injury and Recurrent Urinary Tract Infections.

Authors:  Shu-Yu Wu; Yuan-Hong Jiang; Jia-Fong Jhang; Yung-Hsiang Hsu; Han-Chen Ho; Hann-Chorng Kuo
Journal:  Biomedicines       Date:  2022-01-20

4.  Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months.

Authors:  Su Jin Kim; Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2022-09-30       Impact factor: 3.038

5.  Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Tomohiro Ueda; Philip M Hanno; Ryoichi Saito; Jane M Meijlink; Naoki Yoshimura
Journal:  Int Neurourol J       Date:  2021-06-30       Impact factor: 2.835

Review 6.  Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.

Authors:  Hung-Yu Lin; Jian-He Lu; Shu-Mien Chuang; Kuang-Shun Chueh; Tai-Jui Juan; Yi-Chang Liu; Yung-Shun Juan
Journal:  Diagnostics (Basel)       Date:  2021-12-29

Review 7.  Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.

Authors:  Yoshiyuki Akiyama
Journal:  Diagnostics (Basel)       Date:  2021-11-30

Review 8.  Biomarkers in the Light of the Etiopathology of IC/BPS.

Authors:  Jochen Neuhaus; Mandy Berndt-Paetz; Andreas Gonsior
Journal:  Diagnostics (Basel)       Date:  2021-11-29

9.  Human Umbilical Cord Mesenchymal Stem Cell Therapy Mitigates Interstitial Cystitis by Inhibiting Mast Cells.

Authors:  Yuancheng Xu; Fei Yang; Juncong Xie; Wenbiao Li; Bolong Liu; Jialiang Chen; Honglu Ding; Jiarong Cai
Journal:  Med Sci Monit       Date:  2021-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.